HEPATIC CANCER STAGE II

This adverse event was reported 394 times

These drugs are most commonly taken by patients reporting HEPATIC CANCER STAGE II:

# Drug Count
0 RANITIDINE 40
1 RANITIDINE HYDROCHLORIDE 14
2 DULAGLUTIDE 1
3 EMPAGLIFLOZIN 1
4 ESOMEPRAZOLE MAGNESIUM 1
5 ETANERCEPT 1
6 METFORMIN 1
7 METFORMIN ER 500 MG 1
8 METFORMIN ER 750 MG 1
9 SECUKINUMAB 1
See all common drugs associated with HEPATIC CANCER STAGE II

HEPATIC CANCER STAGE II is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 RANITIDINE HYDROCHLORIDE 14 0.0003
1 RANITIDINE 40 0.0002
2 EMPAGLIFLOZIN 1 0.0000
3 SITAGLIPTIN 1 0.0000
4 DULAGLUTIDE 1 0.0000
5 SECUKINUMAB 1 0.0000
6 ESOMEPRAZOLE MAGNESIUM 1 0.0000
7 METFORMIN ER 500 MG 1 0.0000
8 ETANERCEPT 1 0.0000
See all drugs enriched for association with HEPATIC CANCER STAGE II

HEPATIC CANCER STAGE II is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-17A Antagonist [EPC] 1 0.0000
1 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1 0.0000
2 GLP-1 Receptor Agonist [EPC] 1 0.0000
3 Tumor Necrosis Factor Blocker [EPC] 1 0.0000
See all drug classes enriched for association with HEPATIC CANCER STAGE II